Phibro Animal Health Corporation provided consolidated earnings guidance for the year ending June 30, 2024. For the year, the company expects Net sales of $980 million to $1.02 billion, growth of 2%, Net income of $23 million to $28 million, a decline of 22% and Diluted EPS of $0.57 to $0.69, a decline of 22%.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.7 USD | +0.43% | -2.00% | +52.68% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.68% | 714M | |
-12.95% | 77.37B | |
+24.25% | 3.67B | |
-1.95% | 3.25B | |
+19.26% | 1.73B | |
-25.26% | 1.38B | |
+0.98% | 1.31B | |
-28.25% | 1.24B | |
-19.82% | 1.07B | |
-9.15% | 976M |
- Stock Market
- Equities
- PAHC Stock
- News Phibro Animal Health Corporation
- Phibro Animal Health Corporation Provides Consolidated Earnings Guidance for the Year Ending June 30, 2024